COVID-19 annual update: a narrative review
M Biancolella, VL Colona, L Luzzatto, JL Watt… - Human genomics, 2023 - Springer
Three and a half years after the pandemic outbreak, now that WHO has formally declared
that the emergency is over, COVID-19 is still a significant global issue. Here, we focus on …
that the emergency is over, COVID-19 is still a significant global issue. Here, we focus on …
Tracking the COVID-19 vaccines: The global landscape
ABSTRACT COVID-19, a respiratory infectious disease, occurs due to Severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2). Millions of individuals around the world …
respiratory syndrome coronavirus-2 (SARS-CoV-2). Millions of individuals around the world …
Original SARS-CoV-2 monovalent and Omicron BA. 4/BA. 5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results
S Chalkias, JL Whatley, F Eder, B Essink, S Khetan… - Nature Medicine, 2023 - nature.com
This ongoing, open-label, phase 2/3 trial compared the safety and immunogenicity of the
Omicron BA. 4/BA. 5-containing bivalent mRNA-1273.222 vaccine with the ancestral Wuhan …
Omicron BA. 4/BA. 5-containing bivalent mRNA-1273.222 vaccine with the ancestral Wuhan …
Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study
Background Long-term effectiveness of COVID-19 mRNA boosters in populations with
different previous infection histories and clinical vulnerability profiles is inadequately …
different previous infection histories and clinical vulnerability profiles is inadequately …
Wastewater-based epidemiology predicts COVID-19-induced weekly new hospital admissions in over 150 USA counties
Although the coronavirus disease (COVID-19) emergency status is easing, the COVID-19
pandemic continues to affect healthcare systems globally. It is crucial to have a reliable and …
pandemic continues to affect healthcare systems globally. It is crucial to have a reliable and …
mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States
HF Tseng, BK Ackerson, LS Sy, JE Tubert… - Nature …, 2023 - nature.com
The bivalent (original and Omicron BA. 4/BA. 5) mRNA-1273 COVID-19 vaccine was
authorized to offer broader protection against COVID-19. We conducted a matched cohort …
authorized to offer broader protection against COVID-19. We conducted a matched cohort …
[HTML][HTML] COVID-19 mortality and progress toward vaccinating older adults—World Health Organization, worldwide, 2020–2022
MK Wong - MMWR. Morbidity and mortality weekly report, 2023 - cdc.gov
COVID-19 vaccines are safe and reduce COVID-19 mortality. The World Health
Organization (WHO) recommends that countries prioritize populations at increased risk, eg …
Organization (WHO) recommends that countries prioritize populations at increased risk, eg …
[HTML][HTML] Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
R Grewal, L Nguyen, SA Buchan, SE Wilson… - nature …, 2023 - nature.com
We estimated the effectiveness of booster doses of monovalent mRNA COVID-19 vaccines
against Omicron-associated severe outcomes among adults in Ontario, Canada. We used a …
against Omicron-associated severe outcomes among adults in Ontario, Canada. We used a …
Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine
The rapid emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants that evade immunity elicited by vaccination has placed an imperative on the …
variants that evade immunity elicited by vaccination has placed an imperative on the …
Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study
Summary Background Protection against SARS-CoV-2 symptomatic infection and severe
COVID-19 of previous infection, mRNA two-dose vaccination, mRNA three-dose vaccination …
COVID-19 of previous infection, mRNA two-dose vaccination, mRNA three-dose vaccination …